Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
University of Göttingen · University Hospital of Zurich · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,042
total citations
- FWCI
- 18.23
- Percentile
- 100%
- References
- 33
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- Infliximab
- Psoriasis
- Medicine
- Psoriasis Area and Severity Index
- Placebo
- Internal medicine
- Gastroenterology
- Clinical endpoint
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.